PATENT CLAIM ANALYSIS

Application Number: 15918546
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["548", "301100"]

Abstract:
The present invention relates to spirocyclic acylguanidines and their use as inhibitors of the β-secretase enzyme (BACE1) activity, pharmaceutical compositions containing the same, and methods of using the same as therapeutic agents in the treatment of neurodegenerative disorders, disorders characterized by cognitive decline, cognitive impairment, dementia and diseases characterized by production of β-amyloid aggregates.

Claim (Index 1):
A compound having the following structure: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.40909
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15383287', '13784032', '14613550', '14011183', '14431588']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7230703483469052
- 35 USC 102 Novelty (BERT): 0.4953171436440658
- Combined Prediction Score: 0.7002950278766213
- Mean Citation Score: 248.655014
- Max Citation Score: 251.95163
- Similarity Product: 214.30721923011123

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test